EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of injectable solutions and services, recently announced a second-quarter 2024 dividend of $0.20 per share. The Exton, Pennsylvania-based company’s Board of Directors approved the dividend, which will be payable on May 1, 2024, to shareholders of record as of April 24, 2024.
This dividend declaration from West Pharmaceutical Services follows a successful fiscal year in 2023 when the company generated $2.95 billion in net sales. With over 10,000 team members across 50 sites worldwide, West Pharmaceutical Services plays a crucial role in the pharmaceutical industry, delivering approximately 48 billion components and devices each year.
As a trusted partner to both established and emerging drug developers, West Pharmaceutical Services is committed to ensuring the safe and effective containment and delivery of life-saving and life-enhancing medicines. Its innovative and high-quality products are integral to many patient treatments around the globe.
The company’s shares are traded on the New York Stock Exchange under the ticker symbol WST and are included in the Standard & Poor’s 500 index, underscoring its standing in the financial market.
Investors will undoubtedly view this latest dividend announcement as a positive sign of West Pharmaceutical Services’ financial health and commitment to returning value to its shareholders. As the company continues to innovate and expand its global footprint, it remains an attractive option for those seeking investment opportunities in the pharmaceutical sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.